Our Speakers

Tudor’s work spans across various dimensions of the research - clinical care continuum, from devising AI algorithms to support clinical decision-making in the rare disorders field, to standardisation of clinical terminology and integration with national public and private health systems. Over the course of the last 15 years, he focused on contributing to the clinical phenotyping community by building deep phenotyping tools to aid the decision-making process in clinical genomics and primary care. He led several of the global phenotype standardisation initiatives, including the first Genomics strategy for SNOMED CT. As an entrepreneur, he was the founding CTO of Genome.One – achieving the first clinical accreditation for whole genome sequencing in the Southern Hemisphere, and the co-founder of Pryzm Health – which implemented phenotype-driven rare disease patient stratification methods in primary care. Before joining the Rare Care team at the Perth Children's Hospital where we focused on using phenotype trajectories to build care coordination pathways for patients with rare disorders, he led the Phenomics team at the European Bioinformatics Institute where he contributed to the acceleration of translational and clinical applications of genomic technologies by creating comprehensive disease models using cross-species phenotype data.

Dr Tudor Groza's Session:

• Obstetrics and Gynaecology Symposium
  Date: 19 Sep 2025, Friday | Time: 1025—1205 | Venue: Level 2, PSL2